ESTA

+ Watchlist + Portfolio

Establishment Labs Holdings Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $75.36
52-Week Range: $36.53 – $97.59
Market Cap: $2.13B
P/E (TTM): —
EPS (TTM): -1.27
Dividend Yield: —

Advanced Metrics

Price/Book: 98.65
PEG Ratio: —
Return on Equity: -175.30%
Return on Assets: -3.44%
Gross Margin: 70.49%
Operating Margin: -6.35%
Profit Margin: -15.82%
Current Ratio: 3.84
Debt/Equity: 12.20
Total Debt: $263.67M
Free Cash Flow: $-19.29M
Revenue Growth: 31.70%
Earnings Growth: —
Enterprise Value: $2.32B

ESTA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$161.70M	$165.15M	$166.03M	$211.08M
Cost of Revenue	$55.10M	$58.17M	$56.50M	$64.77M
Gross Profit	$106.59M	$106.98M	$109.53M	$146.31M
Research & Development	$20.27M	$26.43M	$19.71M	$20.25M
Selling, General & Admin	$125.98M	$145.57M	$139.81M	$165.07M
Operating Expenses	$146.25M	$172.00M	$159.51M	$185.32M
Operating Income	-$39.66M	-$65.03M	-$49.99M	-$39.01M
EBITDA	-$56.73M	-$58.31M	-$56.22M	-$22.29M
Pretax Income	-$72.82M	-$78.58M	-$84.63M	-$58.02M
Income Tax	$2.38M	-$81.00K	-$32.00K	-$6.96M
Net Income	-$75.21M	-$78.50M	-$84.60M	-$51.06M
Diluted EPS	-3.08	-3.07	-3.00	-1.72
Diluted Shares	24.46M	25.60M	28.16M	29.62M

ESTA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$66.36M	$40.03M	$90.35M	$75.57M
Receivables	$35.42M	$46.92M	$65.00M	$77.50M
Inventory	$36.58M	$79.47M	$78.77M	$85.61M
Current Assets	$149.90M	$174.90M	$243.04M	$249.94M
Total Assets	$211.06M	$268.64M	$346.83M	$357.17M
Current Liabilities	$38.96M	$57.15M	$68.28M	$82.14M
Long-Term Debt	$175.46M	$188.74M	$219.58M	$247.52M
Total Debt	$179.35M	$192.22M	$225.29M	$264.47M
Total Liabilities	$219.25M	$250.25M	$293.74M	$333.62M
Retained Earnings	-$281.59M	-$360.10M	-$444.69M	-$495.76M
Shareholders' Equity	-$8.19M	$18.39M	$53.09M	$23.55M
Working Capital	$110.94M	$117.75M	$174.76M	$167.80M
Net Debt	$109.11M	$148.70M	$129.23M	$184.36M

ESTA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$52.17M	-$88.51M	-$58.52M	-$50.89M
Capital Expenditure	-$34.27M	-$24.55M	-$15.56M	-$6.72M
Free Cash Flow	-$86.43M	-$113.06M	-$74.08M	-$57.61M
Depreciation & Amortisation	$4.34M	$4.88M	$7.58M	$10.47M
Stock-Based Compensation	$13.36M	$14.86M	$15.37M	$11.82M
Investing Cash Flow	-$34.79M	-$24.55M	-$15.61M	-$7.03M
Financing Cash Flow	$100.25M	$86.23M	$125.89M	$40.43M
Net Change in Cash	$13.30M	-$26.83M	$51.77M	-$17.48M

ESTA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$41.38M	$51.30M	$53.78M	$64.62M	$59.88M
Cost of Revenue	$13.57M	$16.03M	$16.09M	$19.09M	$17.54M
Gross Profit	$27.81M	$35.27M	$37.70M	$45.53M	$42.34M
Research & Development	$5.05M	$5.20M	$4.55M	$5.43M	$5.24M
Selling, General & Admin	$39.70M	$44.18M	$37.17M	$44.03M	$43.60M
Operating Expenses	$44.75M	$49.38M	$41.72M	$49.46M	$48.85M
Operating Income	-$16.95M	-$14.11M	-$4.03M	-$3.93M	-$6.51M
EBITDA	-$11.38M	-$7.04M	-$1.98M	-$1.90M	-$3.31M
Pretax Income	-$19.80M	-$15.59M	-$10.72M	-$11.91M	-$13.09M
Income Tax	$914.00K	$1.00M	$424.00K	-$9.30M	$288.00K
Net Income	-$20.71M	-$16.59M	-$11.15M	-$2.62M	-$13.38M
Diluted EPS	-0.70	-0.57	-0.38	-0.09	-0.45
Diluted Shares	29.48M	28.91M	29.62M	29.80M	29.95M

ESTA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$69.18M	$54.64M	$70.62M	$75.57M	$68.10M
Receivables	$63.24M	$70.09M	$71.44M	$77.50M	$77.08M
Inventory	$90.42M	$94.68M	$88.16M	$85.61M	$86.66M
Current Assets	$231.70M	$229.17M	$239.60M	$249.94M	$245.83M
Total Assets	$333.36M	$329.67M	$338.89M	$357.17M	$351.04M
Current Liabilities	$69.04M	$80.74M	$71.98M	$82.14M	$83.15M
Long-Term Debt	$220.34M	$221.13M	$246.46M	$247.52M	$248.59M
Total Debt	$225.70M	$231.12M	$261.16M	$264.47M	$263.96M
Total Liabilities	$294.81M	$306.90M	$322.53M	$333.62M	$336.25M
Retained Earnings	-$465.40M	-$482.00M	-$493.14M	-$495.76M	-$509.14M
Shareholders' Equity	$38.55M	$22.76M	$16.36M	$23.55M	$14.78M
Working Capital	$162.66M	$148.43M	$167.62M	$167.80M	$162.67M
Net Debt	$151.16M	$171.49M	$185.83M	$184.36M	$191.73M

ESTA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$20.73M	-$18.75M	-$11.25M	-$162.00K	-$4.31M
Capital Expenditure	-$1.03M	-$2.07M	-$1.96M	-$1.66M	-$1.96M
Free Cash Flow	-$21.75M	-$20.82M	-$13.21M	-$1.82M	-$6.27M
Depreciation & Amortisation	$2.57M	$2.60M	$2.54M	$2.77M	$2.69M
Stock-Based Compensation	$2.54M	$3.28M	$2.99M	$3.00M	$3.10M
Investing Cash Flow	-$1.34M	-$2.07M	-$1.96M	-$1.66M	-$1.96M
Financing Cash Flow	-$203.00K	$5.13M	$29.45M	$6.05M	-$864.00K
Net Change in Cash	-$22.26M	-$15.70M	$16.24M	$4.23M	-$7.13M

Market Snapshot

About

Establishment Labs Holdings Inc. is a global medical technology company focused on designing, developing, manufacturing, and marketing innovative medical devices for aesthetic and reconstructive plastic surgery. The company's primary products include breast implants featuring advanced silicone gel technology and proprietary surface designs intended to improve safety and aesthetic outcomes. Establishment Labs markets its products worldwide through direct sales forces and distribution partnerships with plastic surgeons and medical institutions. The company invests in clinical research and product innovation to expand its portfolio of soft tissue reconstruction and augmentation solutions.